Loading...

Home
ETF
ENVB

ENVB

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ENVB News

Enveric Biosciences Closes Direct Offering of Common Stock

Jan 28 2026Yahoo Finance

Enveric Biosciences Announces Direct Offering of Shares

Jan 28 2026seekingalpha

Enveric Secures U.S. Patent Expanding Neuropsychiatric Drug Development

Dec 29 2025Newsfilter

ENvue Appoints David Johnson as Chairman to Drive Feeding Tube Technology Advancement

Dec 15 2025Newsfilter

Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each, Raising $3.1 Million

Dec 12 2025Newsfilter

Enveric Biosciences Exercises 426,390 Warrants at $7.05 Each

Dec 11 2025Newsfilter

What Caused Enveric Biosciences (ENVB) to Soar 74% in After-Hours Trading?

Dec 10 2025Benzinga

Stock Splits Scheduled for This Week (October 27 to October 31) – Keep Your Investments Active

Oct 26 2025TipRanks

Weekly Update on the Cannabis and Psychedelic Industries

Oct 19 2025Yahoo Finance

Enveric Biosciences Achieves Important Manufacturing Milestones for Upcoming IND and Clinical Trials

Oct 02 2025Newsfilter

Enveric Biosciences Reports Completion of Warrant Exercise, Generating $2.2 Million in Gross Proceeds

Sep 18 2025Newsfilter

Enveric Biosciences Receives FDA Feedback on Pre-IND Type B Meeting Request for Lead Program EB-003

Sep 16 2025NASDAQ.COM

Enveric Biosciences to Showcase at H.C. Wainwright's 27th Annual Global Investment Conference

Sep 03 2025Newsfilter

Enveric Biosciences Secures Second U.S. Patent Allowance for Next-Generation, Non-Hallucinogenic Mescaline Derivatives in EVM401 Series

Jul 23 2025Newsfilter

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Jul 20 2025Yahoo Finance

Enveric Biosciences Lead Drug Candidate EB-003 Demonstrates Positive Effects in Preclinical Model of Post-Traumatic Stress Disorder (PTSD)

Jul 15 2025Newsfilter